Ximing Ding, PhD

Associate, Pureos Bioventures 

At Pureos, Ximing is active in deal flow generation, investment due diligence, investment and exit transactions as well as fundraising support. In addition to Tridek-One, Ximing is currently BoD observer at Araris Biotech and Engimmune Therapeutics. He obtained his PhD at the European Molecular Biology Laboratory and holds an MSc. in Biology at ETH Zurich.